ArticleBiomaterials2013

Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma.

Ommoleila Molavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.